Hopp til hovedinnhold

Late-onset nemalin myopati

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Naddaf E1, Milone M2, Kansagra A2, Buadi F2, Kourelis T2. Sporadic late-onset nemaline myopathy: Clinical spectrum, survival, and treatment outcomes. Neurology. 2019. pmid:31167932 PubMed  
  2. Schnitzler LJ1,2, Schreckenbach T3, Nadaj-Pakleza A4, Stenzel W5, Rushing EJ6, Van Damme P7,8,9, Ferbert A10, Petri S11, Hartmann C12, Bornemann A13, Meisel A14, Petersen JA15, Tousseyn T16, Thal DR16,17, Reimann J18, De Jonghe P19,20, Martin JJ21, Van den Bergh PY22, Schulz JB1,23, Weis J2, Claeys KG24,25,26,27,28.. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J Rare Dis. 2017. pmid:28490364 PubMed  
  3. Chahin N1, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005; Oct 25;65(8): 1158-64. pmid:16148261 PubMed  
  4. Voermans NC1, Benveniste O2, Minnema MC2, Lokhorst H2, Lammens M2, Meersseman W2, Delforge M2, Kuntzer T2, Novy J2, Pabst T2, Bouhour F2, Romero N2, Leblond V2, Bergh Pv2, Vekemans MC2, van Engelen BG2, Eymard B2.. Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology 2014; Dec 2;83(23):: 2133-9. pmid:25378674 PubMed  
  5. Zhao B, Dai T, Zhao D, Ma X, Zhao C, Li L, Sun Y, Zhang Y, Yan Y, Lu JQ, Liu F, Yan C. Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti-α-Actinin Immunostaining. Neurol Neuroimmunol Neuroinflamm. 2022 May 17;9(4):e1184. doi: 10.1212/NXI.0000000000001184. PMID: 35581006 PubMed  
  6. Monforte M, Primiano G, Silvestri G, Mirabella M, Luigetti M, Cuccagna C, Ricci E, Servidei S, Tasca G. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort. J Neurol. 2018 Mar;265(3):542-551. PMID: 29356967 PubMed  
  7. Okhovat AA, Nilipour Y, Boostani R, Vahabizad F, Najmi S, Nafissi S, Fatehi F. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: Report of four patients. Neuromuscul Disord. 2021 Jan;31(1):29-34. PMID: 33308940. PubMed  
  8. Kumutpongpanich T, Owattanapanich W, Tanboon J, Nishino I, Boonyapisit K. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen. Neuromuscul Disord. 2018 Jul;28(7):610-613. PMID: 29910095 PubMed  
  • Unn Ljøstad, spesialist i nevrolog, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med